Effect of nebulized budesonide on respiratory mechanics and oxygenation in acute lung injury/acute respiratory distress syndrome: Randomized controlled study
Open Access
- 1 January 2017
- journal article
- research article
- Published by Medknow in Saudi Journal of Anaesthesia
- Vol. 11 (1), 9-14
- https://doi.org/10.4103/1658-354x.197369
Abstract
Background: We tested the hypothesis that nebulized budesonide would improve lung mechanics and oxygenation in patients with early acute lung injury (ALI) and/or acute respiratory distress syndrome (ARDS) during protective mechanical ventilation strategy without adversely affecting systemic hemodynamics. Methods: Patients with ALI/ARDS were included and assigned into two groups; budesonide group (30 cases) in whom 1 mg–2 ml budesonide suspension was nebulized through the endotracheal tube and control group (30 cases) in whom 2 ml saline (placebo) were nebulized instead of budesonide. This regimen was repeated every 12 h for three successive days alongside with constant ventilator settings in both groups. Hemodynamics, airway pressures, and PaO2/FiO2were measured throughout the study period (72 h) with either nebulized budesonide or saline. Furthermore, tumor necrosis factor-alpha (TNF-α), interleukin-1 beta (IL-1β), and interleukin-6 (IL-6) were analyzed serologically as markers of inflammation at pre- and post-nebulization sessions. Results: We found a significant difference between the two groups regarding PaO2/FiO2 (P = 0.023), peak (P = 0.021), and plateau (P = 0.032) airway pressures. Furthermore, TNF-α, IL-1β, and IL-6 were significantly reduced after budesonide nebulizations. No significant difference was found between the two groups regarding hemodynamic variables. Conclusion: Nebulized budesonide improved oxygenation, peak, and plateau airway pressures and significantly reduced inflammatory markers (TNF-α, IL-1β and IL-6) without affecting hemodynamics. Trial Registry: Australian New Zealand Clinical Trial Registry (ANZCTR) at the number: ACTRN12615000373572.Keywords
This publication has 21 references indexed in Scilit:
- Effect of budesonide on fibroblast-mediated collagen gel contraction and degradationJournal of Inflammation Research, 2013
- Acute Respiratory Distress SyndromeJAMA, 2012
- Inhaled corticosteroids as combination therapy with β-adrenergic agonists in airways disease: present and futureEuropean Journal of Clinical Pharmacology, 2009
- Is there evidence to support a phase II trial of inhaled corticosteroids in the treatment of incipient and persistent ARDS?Critical Care and Resuscitation, 2007
- Safety and tolerability of inhaled budesonide in children in the Steroid Treatment As Regular Therapy in early asthma (START) trialPediatric Allergy and Immunology, 2006
- Comparison of Nebulized Budesonide and Oral Prednisolone with Placebo in the Treatment of Acute Exacerbations of Chronic Obstructive Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2002
- Cytokine Balance in the Lungs of Patients with Acute Respiratory Distress SyndromeAmerican Journal of Respiratory and Critical Care Medicine, 2001
- PULMONARY PATHOLOGY OF ACUTE RESPIRATORY DISTRESS SYNDROMEClinics in Chest Medicine, 2000
- The Acute Respiratory Distress SyndromeThe New England Journal of Medicine, 2000
- Aerosol Therapy in Mechanically Ventilated Patients: Recent Advances and New TechniquesSeminars in Respiratory and Critical Care Medicine, 2000